Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula

Affiliations

¹ Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
² Gastroenterology Department, Assistance Publique Hôpitaux de Marseille, CHU of Marseille, Marseille, France.
³ Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Faculté de Pharmacie de Marseille, INSERM, INRA, C2VN, Faculté de Pharmacie de Marseille, Aix Marseille University, Marseille, France.

Comment

Fanny Grimaud et al. Gastroenterology. 2019 Dec.

. 2019 Dec;157(6):1690-1691.

doi: 10.1053/j.gastro.2019.05.078. Epub 2019 Sep 19.

¹ Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
² Gastroenterology Department, Assistance Publique Hôpitaux de Marseille, CHU of Marseille, Marseille, France.
³ Cell Therapy Department, INSERM CBT 1409, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Faculté de Pharmacie de Marseille, INSERM, INRA, C2VN, Faculté de Pharmacie de Marseille, Aix Marseille University, Marseille, France.

No abstract available

Comment on

Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
Dige A, Hougaard HT, Agnholt J, Pedersen BG, Tencerova M, Kassem M, Krogh K, Lundby L. Dige A, et al. Gastroenterology. 2019 Jun;156(8):2208-2216.e1. doi: 10.1053/j.gastro.2019.02.005. Epub 2019 Feb 14. Gastroenterology. 2019. PMID: 30772343 Clinical Trial.